Tumor-specific gene delivery mediated by a novel peptide-polyethylenimine- DNA polyplex targeting aminopeptidase N/CD13

Human Gene Therapy

Volumn 16, Issue 1, 2005, Pages 57-67

  Moffatt, Stanley ^a   Wiehle, Sandra ^a   Cristiano, Richard J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENEBORONIC ACID; BETA GALACTOSIDASE; BORONIC ACID DERIVATIVE; CYSTEINYLASPARAGINYLGLYCYLARGINYLCYSTEINE; MACROGOL; MICROSOMAL AMINOPEPTIDASE; PEPTIDE; PHENYLDIBORONIC ACID; POLYETHYLENEIMINE; SALICYLHYDROXAMIC ACID; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLADDER CANCER; DNA PROTEIN COMPLEX; DNA VECTOR; DRUG FORMULATION; ENDOTHELIUM CELL; FEMALE; FIBROSARCOMA; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LUNG CANCER; MOUSE; NONHUMAN; NUDE MOUSE; PLASMID; STEREOSPECIFICITY;

ANIMALS; ANTIGENS, CD13; BETA-GALACTOSIDASE; CELLS, CULTURED; DNA; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; FEMALE; FIBROSARCOMA; GENE TARGETING; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; TRANSDUCTION, GENETIC; UMBILICAL VEINS; URINARY BLADDER NEOPLASMS;

EID: 13844292521     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.57     Document Type: Article

References (40)

1. ARAP, W., PASQUALINI, R., and RUOSLAHTI, E. (1998). Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279, 377-380.
2. BALASUBRAMANIAM, R.P., BENNETT, A.M., ABERLE, J.G., MALONE, M.H., and NANTZ, R.W. (1996). Structural and functional analysis of cationic transfection lipids: The hydrophobic domain. Gene Ther. 3, 163-172.
3. BAO, J.J., ZHANG, W.W., and KUO, M.T. (1996). Adenoviral delivery of recombinant DNA into transgenic mice bearing hepatocellular carcinomas. Hum. Gene Ther. 7, 355-365.
4. CHOWDHURY, N.R., WU, C.H., WU, G.Y., YERNENI, P.C., BOMMINENI V.R., and CHOWDHURY, J.R. (1993). Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocycosis in vivo. J. Biol. Chem. 268, 11265-11271.
5. COLL, J.L., NEGOESCU, A., LOUIS, N., SACHS, L., TENAUD, C., GIRARDOT, V., DEMEINEX, B., BRAMBILLA, E., BRAMBILLA, C., and FAVROT, M (1998). Antitumor activity of bax and p53 naked gene transfer in lung cancer: In vitro and in vivo analysis. Hum. Gene Ther. 9, 2063-2074.
6. COLL, J.L., CHOLLET, P., BRAMBILLA, E., DESPLANQUES, D., JEAN-PAUL, B., and FAVROT, M. (1999). In vivo delivery to tumors of DNA complexed with linear polyethyleneimine. Hum. Gene Ther. 10, 1659-1666.
7. CRISTIANO, R.J., SMITH, L.C., and WOO, S.L. (1993). Hepatic gene delivery: Adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 90, 2122-2126.
8. ELLERBY, H.M., ARAP, W., ELLERBY, L.M., KAIN, R., ANDRUSIAK, R., DEL RIO, G., KRAJEWSKI, S., LOMBARDO, C.R., RAO, R., RUOSLAHTI, E., BREDESEN, D.E., and PASQUALINI, R. (1999). Anti-cancer activities of targeted pro-apoptotic peptides. Nat. Med. 5, 1032-1038.
9. FERKOL, T., KAETZEL, C.L., and DAVIS, P.B. (1993). Gene transfer into respiratory cells by targeting the polymeric immunoglobulin receptor. J. Clin. Invest. 92, 2394-2400.
10. FISHER, K.D., ULBRICH, K., SUBR, V., WARD, C.M., MAUTNER, V., BLAKEY, D., and SEYMOUR, L.W. (2000). A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression. Gene Ther. 7, 1337-1343.
11. GORMAN, C.M., AIKAWA, M., FOX, B., FOX, E., LAPUZ, C., MICHAUD, B., NGUYEN, H., ROCHE, E., SAWA, T., and WIENER-KRONISH, J.P. (1997). Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC. Gene Ther. 4, 983-992.
12. HEISE, C.C., WILLIAMS, A.M., XUE, S., PROPST, M., and KIRN, D.H. (1999). Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy. Cancer Res. 59, 2623-2628.
13. HOLLE, L., SONG, W., HICKS, L., HOLLE, E., HOLMES, L., WEI, Y., LI, J., WAGNER, T., and YU, X. (2004). In vitro targeted killing of human endothelial cells by co-incubation of human serum and NGR peptide conjugated human protein bearing α(1-3) galactose epitopes. Oncol. Rep. 11, 613-616.
14. JENKINS, R.G., HERRICK, S.E., MENG, Q.H., KINNON, C., LAURENT, G.J., McANULTY, R.J., and HART, S.L. (2001). An integrin-targeted non-viral vector for pulmonary gene therapy. Gene Ther. 7, 393-400.
15. LARSON-IRWIN, D. (2000). Bioconjugate chemistry: An evolution of cools for proteomics and genomics. Modern Drug Discov. 3, 79-80.
16. LEE, E.R., MARSHALL, J., SIEGEL, C.S., JIANG, C., YEW, N.S., NICHOLS, M.R., NIETUPSKI, J.B., ZIELER, R.J., LANE, M.B., WANG, K.X., WAN, N.C., SCHEULE, R.K., HARRIS, D.J., SMITH, A.E., and CHENG, S.H. (1996). Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Gene Ther. 7, 1701-1717.
17. LOOK, A.T., ASHMUN, R.A., SHAPIRO, L.H., and PEIPER, S.C. (1989). Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J. Clin. Invest. 83, 1299-1307.
18. OLSEN, J., KOKHOLM, K., NOREN, O., and SJOSTROM, H. (1997). Structure and expression of aminopeptidase N. Adv. Exp. Med. Biol. 421, 47-57.
19. PASQUALINI, R., KOIVUNEN, E., and RUOSLAHTI, E. (1995). A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J. Cell Biol. 130, 1189-1196.
20. PASQUALINI, R., and RUOSLAHTI, E. (1996). Organ targeting in vivo using phage display peptide libraries. Nature 380, 364-366.
21. PASQUALINI, R., KOIVUNEN, E., KAIN, R., LAHDENRANTA, J., SAKAMOTO, M., STRYHN, A., ASHMUN, R.A., SHAPIRO, L.H., ARAP, W., and RUOSLAHTI, E. (2000). Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 60, 722-727.
22. PERALES, J.C., GROSSMAN, G.A., MOLAS, M., LIU, G., FERKOL, T., HARPST, J., ODA, H., and HANSON, R.W. (1997). Biochemical and functional characterization of DNA complexes capable of targeting genes to hepatocytes via the of DNA complexes capable of targeting genes to hepatocytes via the asialoglycoprotein receptor. J. Biol. Chem. 272, 7398-7407.
23. RAJOTTE, D., ARAP, W., HAGEDORN M., KOIVUNEN, E., PASQUALINI, R., and RUOSLAHTI, E. (1998). Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Invest. 102, 430.
24. RIEMANN, D., KEHLEN, A., THIELE, K., LOHN, M., and LANGNER, J. (1997). Induction of aminopeptidase N/CD13 on human lymphocyte after adhesion to fibroblast-like synoviocyte endothelial cells, epithelial cells, and monocytes/macrophages. J. Immunol. 158, 3425-3432.
25. SHIPP, M.A., and LOOK, A.T. (1993). Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key! Blood 82, 1052-1070.
26. SMREKAR, B., WIGHTMAN, L., WOLSCHEK, M.F., LICHTENBERGER, C., RUZICKA, R., OGRIS, M., RODL, W., KURSA, M., WAGNER, E., and KIRCHEIS, R. (2003). Tissue-dependent factors affect gene delivery to tumors in vivo. Gene Ther. 10, 1079-1088.
27. SOLODIN, I., BROWN, C.S., BRUNO, M.S., CHOW, C.Y., JANG, E.H., DEBS, R.J., and HEATH, T.D. (1995). A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery. Biochemistry 34, 13537-13544.
28. STOLOWITZ, M.L., AHLEM, C., HUGHES, K.A., KAISER, R.J., KESICKI, E.A., LI, G., LUND, K.P., TORKELSON, S.M., and WILEY, J.P. (2001). Phenylboronic acid-salicylhydroxamic acid bioconjugates: A novel boronic acid complex for protein immobilization. Bioconjug. Chem. 12, 229-239.
29. SWEENY, P., KARASHIMA, T., ISHIKURA, H., WIEHLE, S., YAMASHITA, M., BENEDICT, W.F., CRISTIANO, R.J., and DINNEY, C.P.N. (2003). Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model. Cancer Res. 63, 4017-4020.
30. VAN HENSBERGEN, Y., BROXTERMAN, H.J., ELDERKAMP, Y.W., LANKELMA, J., BEERS, J.C.C., HEIJN, M, BOVEN, E., HOEKMAN, K., and PINEDO, H.M. (2002). A doxorubicin-CNGRC peptide conjugate with prodrug properties. Biochem. Pharm. 63, 897-908.
31. VERBAAN, F.J., OUSSOREN, C., VAN DAM, I.M., TAKAKURA, Y., HASHIDA, M., CROMMELIN, D.J., HENNINK, W.E., and STORM, G. (2001). The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration. Int. J. Pharm. 214, 99-101.
32. WORGALL, S., WOLFF, G., FALCK-PEDERSEN, E., and CRYSTAL, R.G. (1997). Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8, 37-44.
33. WU, C.H., WILSON, J.M., and WU, G.Y. (1989). Targeting genes: Delivery and persistent expression of a foreign gene driven by mammalian regulator elements in vivo. J. Biol. Chem. 264, 16985-16987.
34. WU, G.Y., and WU, C.H. (1987). Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262, 4429-4432.
35. YANG, Y., XIANG, Z., ERTL, H.C.J., and WILSON, J.M. (1995a). Upregulation of class 1 major histocompatibility complex antigens by interferon γ is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. U.S.A. 92, 7257-7261.
36. YANG, Y., TRINCHIERI, G., and WILSON, J.M. (1995b). Recombinant IL-12 prevents the formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 9, 890-893.
37. ZHDANOV, R.I., PODOBED, O.V., and VLASSOV, V.V. (2004). Cationic lipid-DNA complexes-lipoplexes for gene transfer and therapy. Bioelectrochemistry 58, 53-64.
38. ZIADY, A., FERKOL, T., GERKEN, T., DAWSON, D.V., PERLMUTTER, D.H., and DAVIS, P.B. (1998). Ligand substitution of receptor-targeted DNA complexes affects gene transfer into hepatoma cells. Gene Ther. 5, 1685-1697.
39. ZIADY, A., FERKOL, T., DAWSON, D.V., PERLMUTTER, D.H., and DAVIS, P.B. (1999). Chain length of the polymer portion of receptor-targeted DNA complexes modulates gene transfer both in vitro and in vivo. J. Biol. Chem. 274, 4908-4916
40. ZOU, Y., ZONG, G., LING, Y.H., PEREZ-SOLER, R. (2000). Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer. Cancer Gene Ther. 7, 683-696.